NCT07045051

Brief Summary

Large blood sugar and insulin increases after meals high in table sugar are related to risk for diabetes and heart disease. Additionally, large increases in blood sugar may also negatively impact vascular health. Previous research suggests that mango consumed in small quantities has blood sugar-lowering properties, but the evidence of this within larger, more realistic meals is limited. The investigators want to understand if replacing table sugar (sucrose) with sugar from fresh mango (which also contains fiber and plant bioactives) will lead to more favorable blood sugar, insulin, and vascular responses after eating breakfast meals. The investigators will compare the postprandial glycemic, insulinemic, and vascular response to low and high glycemic meals sweetened with either fresh mango or sucrose.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Mar 2025Dec 2026

Study Start

First participant enrolled

March 26, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 24, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 1, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

1.7 years

First QC Date

June 24, 2025

Last Update Submit

June 24, 2025

Conditions

Keywords

glycemiainsulinemiafresh mangovascular health

Outcome Measures

Primary Outcomes (3)

  • Glucose

    The investigators will measure glucose at baseline and .5-, 1-, 2-, and 3-hours after each meal. These measurements will take place immediately and a complete dataset will be compiled upon study completion.

    Through study completion, up to 1.5 years.

  • Insulin

    The investigators will measure insulin at baseline and .5- 1-, 2-, and 3-hours after each meal containing. These measurements will take place immediately and a complete dataset will be compiled upon study completion.

    Through study completion, up to 1.5 years.

  • Flow-mediated Dilation

    The investigators will measure FMD at baseline and 1-, 2-, and 3-hours after the meal. These measurements will take place immediately and a complete dataset will be compiled upon study completion.

    Through study completion, up to 1 year.

Secondary Outcomes (4)

  • HDL-C

    Through study completion, up to 1 year.

  • Triglycerides

    Through study completion, up to 1 year.

  • Acceptability

    Through study completion, up to 1 year.

  • Satiety

    Through study completion, up to 1 year.

Other Outcomes (2)

  • Body Composition

    Through study completion, up to 1 year.

  • Systolic and Diastolic Pressure

    Through study completion, up to 1 year.

Study Arms (4)

Cereal Consumption with Mango

EXPERIMENTAL

During the Cereal and Mango arm, participants will consume a bowl of corn flakes with 2% milk sweetened with fresh mango.

Other: High-Glycemic Breakfast Containing Cereal and Mango

Cereal Consumption with Table Sugar

EXPERIMENTAL

During the Cereal and Table Sugar arm, participants will consume a bowl of corn flakes with 2% milk sweetened with table sugar.

Other: High-Glycemic Breakfast Containing Cereal and Table Sugar

Oat Consumption with Mango

EXPERIMENTAL

During the Oats and Mango Arm, participants will consume a bowl of oats prepared with water and sweetened with fresh mango.

Other: Low-Glycemic Breakfast Containing Oats and Mango

Oat Consumption with Table Sugar

EXPERIMENTAL

During the Oat and Table Sugar arm, participants will consume a bowl of oats prepared with water and sweetened with table sugar.

Other: Low-Glycemic Breakfast Containing Oats and Table Sugar

Interventions

Low-glycemic breakfast of 80 grams of oats prepared with 473mL water and sweetened with 146 grams of mango.

Oat Consumption with Mango

High-glycemic breakfast of 84 grams of corn flakes prepared with 355mL of 2% milk and sweetened with 262 grams of mango.

Cereal Consumption with Mango

Low-glycemic breakfast of 80 grams of oats prepared with 473mL of water and sweetened with 20 grams of table sugar.

Oat Consumption with Table Sugar

High-glycemic breakfast of 84 grams of corn flakes prepared with 355mL of 2% milk and sweetened with 36 grams of table sugar.

Cereal Consumption with Table Sugar

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years.
  • Body mass index between 18.5-35.0 kg/m2
  • Not pregnant (females only)
  • Not postmenopausal (females only).
  • Not been diagnosed with cardiovascular disease.
  • Not been diagnosed with a cardiometabolic conditions (e.g., type 2 diabetes)
  • Not been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
  • Does not regularly take anti-inflammatory drugs (more than 2x week).
  • Does not use glucose-lowering drugs (e.g., metformin)
  • Does not use lipid-lowering drugs (e.g., statins)
  • Does not use tobacco products or any illicit drugs.
  • Does not have a pacemaker.
  • Can consume mango, wheat, gluten, and milk.
  • Can stay in a supine position in the dark for at least ten minutes.

You may not qualify if:

  • Not between the ages of 18-45
  • Body mass index \< 18.5 kg/m2 or \>35.0 kg/m2
  • Pregnant (females only)
  • Postmenopausal status (females only).
  • Been diagnosed with cardiovascular disease.
  • Been diagnosed with a cardiometabolic conditions (e.g., type 2 diabetes)
  • Been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
  • Regularly take anti-inflammatory drugs (more than 2x week).
  • Uses glucose-lowering drugs (e.g., metformin)
  • Uses lipid-lowering drugs (e.g., statins)
  • Uses tobacco products or any illicit drugs.
  • Have a pacemaker.
  • Allergic to mango, wheat, gluten, and/or milk.
  • Unable to lay in supine position in the dark for at least ten minutes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Professions Building, Ball State University

Muncie, Indiana, 47306, United States

RECRUITING

MeSH Terms

Interventions

Mangifera indica extractDietary Sucrose

Intervention Hierarchy (Ancestors)

Dietary SugarsDietary CarbohydratesCarbohydratesSucroseDisaccharidesOligosaccharidesPolysaccharidesSugarsNutritive SweetenersSweetening AgentsFlavoring AgentsFood AdditivesFood IngredientsSpecialty Uses of ChemicalsChemical Actions and UsesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Bryant Keirns, PhD

    Ball State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bryant Keirns, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2025

First Posted

July 1, 2025

Study Start

March 26, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 1, 2025

Record last verified: 2025-06

Locations